Browsing Other ICR Research by author "Au, Lewis"
Now showing items 1-1 of 1
-
Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma.
Au, L; Hatipoglu, E; Robert de Massy, M; Litchfield, K; Beattie, G; et al. (CELL PRESS, 2021-11-08)ADAPTeR is a prospective, phase II study of nivolumab (anti-PD-1) in 15 treatment-naive patients (115 multiregion tumor samples) with metastatic clear cell renal cell carcinoma (ccRCC) aiming to understand the mechanism ...